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Introduction
Inhibitor of differentiation/DNA binding (Id) proteins
belong to a subfamily of helix–loop–helix (HLH) proteins.
Four mammalian members of this family (Id1–Id4) have
been identified. The distinguishing characteristic of Id
proteins is that, unlike the basic HLH proteins, they do
not contain a basic DNA binding domain. Nevertheless,
they can regulate cell functions primarily by dimerization
with other transcriptional regulators, principally basic
HLH proteins.
There is extensive documentation that Id proteins promote
cell proliferation and negatively regulate differentiation.
High levels of Id gene expression have also been
observed in tumor cell lines derived from different tissues
[1,2]. In accordance with this, one of the members of this
gene family (Id-1) has been shown to promote proliferation
and to inhibit functional differentiation of mouse mammary
epithelial cells (SCp2 cells), maintained in cell culture [3].
The normal mammary gland is composed of several cell
types, but it is the luminal epithelial cells lining the inside
of the ducts and the lobules that are primarily targeted for
proliferation, differentiation and carcinogenesis. Therefore,
to assess the precise significance of any regulatory factor
in mammary biology and its significance to carcinogene-
sis, it is essential to examine its cellular localization in vivo.
This is particularly important in the case of ubiquitously
expressed proteins, such as Ids. Accordingly, in the
present study we examined the in situ localization of Id-1
HLH = helix–loop–helix; Id = inhibitor of differentiation/DNA binding.
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Abstract
Background: The family of inhibitor of differentiation/DNA binding
(Id) proteins is known to regulate development in several tissues.
One member of this gene family, Id-1, has been implicated in
mammary development and carcinogenesis. Mammary glands
contain various cell types, among which the luminal epithelial cells
are primarily targeted for proliferation, differentiation and
carcinogenesis. Therefore, to assess the precise significance of
Id-1 in mammary biology and carcinogenesis, we examined its
cellular localization in vivo using immunohistochemistry.
Methods: Extracts of whole mammary glands from wild type
and Id-1 null mutant mice, and tissue sections from paraffin-
embedded mouse mammary glands from various
developmental stages and normal human breast were
subjected to immunoblot and immunohistochemical analyses,
respectively. In both these procedures, an anti-Id-1 rabbit
polyclonal antibody was used for detection of Id-1.
Results: In immunoblot analyses, using whole mammary gland
extracts, Id-1 was detected. In immunohistochemical analyses,
however, Id-1 was not detected in the luminal epithelial cells of
mammary glands during any stage of development, but it was
detected in vascular endothelial cells.
Conclusion: Id-1 is not expressed in the luminal epithelial cells
of mammary glands.
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in normal mammary glands, and we report that Id-1 is not
expressed in the luminal epithelial cells.
Materials and methods
The source of mammary tissues, FVB and BALB/c strains
of mice, used for developmental studies were as follows:
pubertal (6 weeks old), adult nulliparous (12 weeks old),
early pregnant (6 days gestation), lactating (day 7, post-
partum), and postlactational involution (3 days after pup
removal). Id-1 null mutant mice (129Sv/C57BL) have
been described previously [4]. For these null mutant mice,
the corresponding strain of wild type mice was used as a
control. The mice were housed and cared for in accor-
dance with the National Institutes of Health guide to
humane use of animals in research.
For immunoblot analyses, tissues were frozen in liquid
nitrogen and stored at –70°C until use. For immunohisto-
chemical analyses, mammary glands were fixed in 4.7%
buffered formalin, dehydrated, embedded in paraffin and
cut into 5µm thick sections. Tissue sections from paraffin-
embedded normal human breast were kindly provided by
Dr Paul Yaswen.
Source of anti-Id-1 antibody
An anti-Id-1 rabbit polyclonal antibody (C-20) and the
peptide used for the generation of the antibody were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA).
Immunoblot analyses
Protein extracts were prepared from mammary tissues by
homogenization in lysis buffer (50 mM Tris–HCl [pH 8.0],
125 mM NaCl, 1 mM sodium fluoride, 1 mM sodium ortho-
vanadate, 10 mM sodium pyrophosphate and 1 mM
phenylmethylsulfonyl fluoride) containing the protease
inhibitors leupeptin, pepstatin and aprotinin, each at a final
concentration of 1µg/ml. The homogenates were soni-
cated, centrifuged at 110 g, and the pellets were dis-
carded. Protein concentrations in the supernatants
(lysates) were determined by DC protein assay (BioRad,
Hercules, CA, USA). Aliquots of mammary gland lysates
equivalent to 40µg protein were subjected to elec-
trophoresis through 10–20% gradient gels and trans-
ferred to nitrocellulose membranes. The membranes were
blocked with 10% nonfat powdered milk prior to treatment
with the primary antibody. The blots were subsequently
washed and treated with appropriate secondary antibod-
ies. The resulting antigen–antibody complexes were
detected by the ECL system (Amersham Pharmacia
biotech, Chalfont, UK).
Analysis for in situ localization of Id-1
For immunohistochemistry, tissue sections were depara-
ffinized, rehydrated, and soaked in antigen unmasking
solution (Vector, Burlingame, CA, USA), The sections
were then heated in the microwave oven for 21 min to
reveal antigens. The sections were incubated with Immuno
Pure Peroxidase Suppressor (Pierce, Rockford, IL, USA)
to quench the endogenous peroxidase for 1 hour. The
Biotin/Avidin blocking kit (Vector) was then used to block
the nonspecific background. The antigen–antibody com-
plexes were identified using the Universal DAKO LSAB2-
labeled streptavidin–biotin peroxidase kit (DAKO,
Carpinteria, CA, USA). The sections were counterstained
with Mayer’s hematoxylin solution (DAKO).
Results
Validation of the antibody
The Id-1 antibody used in the present studies (C-20) was
the same as that used previously in immunoblot analyses
for demonstrating Id-1 expression in various tissue/cell
extracts, including mammary cells [3,5–8]. As shown in
Figure 1, in immunoblot analyses of whole mammary gland
extracts of wild type mice (lanes 1 and 3 corresponding to
129Sv/C57BL and FVB, respectively), two immunoreactive
bands were detected in the region of 15–20kDa. Among
these, the top band was absent in extracts prepared from
mammary glands of Id-1 null mutant mice (Fig.1, lane 2),
indicating that it corresponded to Id-1. In contrast, in
extracts of wild type mouse testis, as reported previously
[5], a single immunoreactive band was detected (Fig.1,
lane 4) and this corresponded to the top band in mammary
extracts. Similarly, only the top band was detected in
extracts of wild type mouse uterus and intestine (Fig.1,
lanes 5 and 6, respectively). Both the top and the bottom
bands, detected in mammary extracts of wild type mice,
were absent when blots were incubated with Id-1 antibody
in the presence of the peptide used for generation of the
antibody (Fig.1, lane 7). These bands were also absent
with the deletion of the primary antibody (data not shown).
These observations thus confirmed that the C-20 antibody
was capable of detecting Id-1, and also demonstrated its
presence in whole mammary gland extracts.
The C-20 antibody is known to detect Id-1 in paraffin-
embedded tissue sections and has been used successfully
for the analyses of Id-1 in sertoli cells of testis by immuno-
histochemistry [5]. Nevertheless, we verified the ability of
the C-20 antibody to detect Id-1, with fidelity, in immuno-
histochemical analyses. To achieve this we analyzed the
vasculature of the developing brain, since Id-1 gene
expression has been demonstrated previously in this tissue,
by in situ hybridization [9]. Immunoreactivity was detected
in the nuclei of the vasculature of the developing brain, as
shown in Figure 2A,B, and the pattern of immunostaining
was similar to that observed for Id-1 gene expression.
Id-1 is not detectable in luminal epithelial cells of
mammary glands
We next examined the in situ localization of Id-1 in
mammary glands. As shown in Figure 3A, immunoreactiv-
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ity was not detected either in the luminal epithelial cells or
in the stroma of mammary glands of adult nulliparous
females. Immunoreactivity was detected, however, in the
cytoplasm of myoepithelial cells, and this was completely
abolished in the presence of the blocking peptide used for
the generation of Id-1 (C-20) antibody (Fig. 3B). Neverthe-
less, the staining observed in the myoepithelial cells did
not appear to be specific to Id-1 since it was also present
in mammary myoepithelial cells of Id-1 null mutant mice
(compare Fig. 3D and 3E). Similar to mouse mammary
glands, Id-1 immunoreactivity was also not observed in
luminal epithelial cells of normal human mammary glands,
but was detected in the myoepithelial cells (Fig. 3C).
The fact that Id-1 could be detected in mouse mammary
tissue extracts by immunoblot analyses but was unde-
tectable in mammary cells by immunohistochemical analy-
ses led us to consider that the Id-1 detected in tissue
extracts might have been derived from nonmammary cells.
A potential source was vascular endothelial cells since
Id-1 is also expressed in the blood vessels outside the
central nervous system [9]. Immunoreactivity was
detected in the vascular endothelial cells in mammary
glands of wild type adult mice (Fig. 3F), but not in the cells
of Id-1 null mutant mice (Fig. 3E, inset).
It is well known that mammary epithelial cells of adult non-
pregnant females, for the most part, are mitotically quies-
cent and proliferate extensively only with the onset of
pregnancy [10]. Therefore, to examine whether the lack of
expression of Id-1 in the luminal epithelial cells was related
to its quiescent state, we also analyzed the tissues from
early pregnant females. The patterns of immunostaining in
mammary glands did not change either during pregnancy
Available online http://breast-cancer-research.com/content/5/2/R25
Figure 1
Immunoblot analyses for Id-1 in various mouse tissues. Lysates were
prepared from various mouse tissues and analyzed for Id-1, using C-20
antibody, as described in the text. The positions of the molecular
weight standards (kDa) are shown on the right. Lanes 1 and 3, wild
type mammary glands (129Sv/C57BL and FVB, respectively); lane 2,
mammary glands from Id-1 null mutant mouse; lanes 4–6, testis, uterus
and intestine from wild type mice, respectively; lane 7, mammary gland
extract of wild type mice in which treatment with the primary antibody
was performed in the presence of the blocking peptide.
Figure 2
Immunohistochemical analyses for Id-1. (A), (B) The immunoreactivity
in the vasculature (arrows) of the developing brain (inset, B) at day
12.5 of gestation. Original magnification, (A) 50 ×, (B) 400 ×.
Figure 3
Immunohistochemical analyses for Id-1 in mammary glands. All tissue sections were treated with the primary antibody (except (B), which was
incubated with both the primary antibody and the blocking peptide) and processed as described in the text. (A), (B) Adult nulliparous wild type
mice (FVB), (C) normal human mammary gland, (D) adult nulliparous wild type mice (129Sv, C57BL/6) corresponding to the strain of Id-1 null
mutant mice, (E) arrows showing the vascular endothelial cells, and (F) vascular endothelial cells (arrows) in an artery (A) and a vein (V) in
mammary glands of wild type mice. Original magnification: (A)–(E) 400 ×. Insets of (A) and (E), higher magnification (630 ×).
(Fig.4A), during lactation (Fig.4B) or during postlactational
involution (Fig.4C). As such, immunoreactivity was still
confined to the cytoplasm of the myoepithelial cells and
was not detected in luminal epithelial cells. Similar results
were also obtained with tissues isolated from the Balb/c
strain of mice (data not shown), the strain from which
SCp2 cells had been derived [11]. In addition to preg-
nancy, mammary glands also proliferate extensively at the
onset of puberty and, in these glands, the site of intense
mitotic activity resides in specialized structures called the
terminal end buds [12]. In terminal end buds of pubertal
females, immunoreactivity was not detected either in the
body cells or the cap cells (Fig.4D) present at the tips.
Discussion
In the present report, we have demonstrated that Id-1 is not
detectable in the luminal epithelial cells of both mouse and
human mammary glands. Our inability to detect Id-1 in
these cells is not related to the source of the antibody or
techniques since it was possible to detect Id-1 in vascular
endothelial cells by immunohistochemistry and via
immunoblot analyses of several mouse tissue extracts,
including mammary glands. The fact that Id-1 is detected in
mammary tissue extracts by immunoblot analyses but not
by immunohistochemical analyses therefore indicates that
Id-1 detected in whole tissue extracts is derived from non-
mammary cells. This argument is supported by our demon-
stration that Id-1 is expressed in vascular endothelial cells
of mammary glands. Furthermore, in contrast to Id-1, we
can detect Id-2 in the luminal epithelial cells of mouse
mammary glands (N Uehara, Y-C Chou and G Shyamala,
unpublished observation) in which Id-2 gene expression
has been demonstrated by in situ hybridization [13]. Based
on all these observations, we conclude that Id-1 is not
expressed in the luminal epithelial cells of mammary glands.
Our studies also demonstrate clearly that in mice, regard-
less of the strain or the developmental stage, Id-1 is not
detectable in the luminal epithelial cells; this included both
puberty and early pregnancy, when mammary glands
undergo extensive proliferation. Accordingly, our present
observations do not support the previous suggestion that,
in mammary epithelial cells, Id-1 is a positive and a nega-
tive regulator of proliferation and of differentiation, respec-
tively [3]. In turn, the observations also emphasize that the
postulated roles for Id-1, using various cell culture models,
may not be applicable to all cell types, particularly in vivo
[2]. This is exemplified by the fact that much of the infor-
mation demonstrating various regulatory roles for Id pro-
teins have used fibroblasts and, as shown here, mammary
fibroblasts do not express Id-1.
Finally, the detection of ‘non-Id-1’ immunoreactivity in
immunoblot analyses and in myoepithelial cells, with
immunohistochemistry, requires comment. It is clearly not
due to an abundant nonspecific protein since the
immunoreactivity associated with the myoepithelial cells is
quite discreet. Indeed, the immunoreactivity associated
with the myoepithelial cells is completely abolished by the
blocking peptide (Fig. 2). It is also not due to Id-2 or Id-3,
since this antibody is specific to an epitope in the carboxy
terminus of Id-1 and has no crossreactivity with these pro-
teins [6,8]. Furthermore, the nonspecific band detected in
immunoblots appears to have some specificity for
mammary glands since, to date, we have not detected this
band in other mouse tissue extracts. Also, the nonspecific
band is eliminated upon exposure to the blocking peptide.
Myoepithelial cells express a number of proteins but
several of these are also expressed by luminal epithelial
cells [14]. As such, very few proteins are expressed exclu-
sively in the myoepithelial cells, the most prominent one
being alpha smooth muscle actin [15]. It is, however,
unlikely, that the ‘non-Id-1’ immunoreactivity associated
with myoepithelial cells is alpha smooth muscle actin since
it has minimal homology to Id-1 and, in particular, to the
peptide used for the generation of the antibody. It is there-
fore most probably due to some other smooth muscle cell-
specific protein capable of recognizing the epitope on the
Id-1 (C-20) antibody. Identification of this protein can thus
lead to establishing another myoepithelial cell-specific
marker, which in turn can contribute to our current under-
standing of the biology of mammary myoepithelial cells.
Conclusion
Id-1 detected in whole mammary gland extracts is not
derived from luminal epithelial cells.
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Figure 4
Immunohistochemical analyses for Id-1 in mouse mammary glands
during various phases of development. Mammary glands from (A) early
pregnant, (B) lactating, (C) lactational involuting and (D) pubertal mice
were analyzed for the presence of Id-1 as described in the text. Note
that, in all the mammary ducts, immunoreactivity is present only in
myoepithelial cells and not in the luminal cells. Immunoreactivity is also
not detected in the terminal end bud of the pubertal mouse. Original
magnification, 400 ×.
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